Yi He MD, PhD , Mingzhe Xu MD , Zhi Li MD , Jiaqi Yu , Qian Li MD, PhD , Yunxia Zuo MD, PhD , Yi Kang MD , Bin Du MD
{"title":"Ultrasound-guided bilateral serratus plane block versus thoracic paravertebral block following minimally invasive pectus excavatum repair in children: A randomized controlled non-inferiority study.","authors":"Yi He MD, PhD , Mingzhe Xu MD , Zhi Li MD , Jiaqi Yu , Qian Li MD, PhD , Yunxia Zuo MD, PhD , Yi Kang MD , Bin Du MD","doi":"10.1016/j.jclinane.2025.112003","DOIUrl":null,"url":null,"abstract":"<div><h3>Study objective</h3><div>This study evaluated whether ultrasound-guided serratus anterior plane block (SAPB) provided non-inferior analgesic effects for minimally invasive pectus excavatum repair surgery compared with thoracic paravertebral block (TPVB).</div></div><div><h3>Design</h3><div>A noninferiority randomized trial.</div></div><div><h3>Setting</h3><div>West China Hospital of Sichuan University.</div></div><div><h3>Patients</h3><div>Seventy-four children aged 7–16 years who underwent minimally invasive pectus excavatum repair surgery were enrolled.</div></div><div><h3>Intervention</h3><div>Patients were randomly assigned to receive bilateral SAPB (<em>n</em> = 37) or TPVB (n = 37) after induction of anesthesia (0.5 mL kg<sup>−1</sup> 0.25 % of ropivacaine per side)<strong>.</strong></div></div><div><h3>Measurements</h3><div>Pain scores assessed via numerical rating scale (NRS) postoperatively; opioid consumption, block-related complications; and plasma ropivacaine concentrations were measured.</div></div><div><h3>Main results</h3><div>Median (IQR) pain scores for SAPB were 1 (1.0–2.0) and 1 (0.5–2.0) for those with TVPB 24 h postoperatively (effect size = 0.027; 95 % confidence interval, −0.42 to 0.47, <em>P</em> = 0.905), meeting the non-inferiority criterion with a pre-specified margin of 0.5. The TPVB group exhibited a greater incidence of hypotension (29.7 % vs. 8.1 %, <em>p</em> = 0.018). The ropivacaine concentrations were lower in the SAPB group at all measured time points (SAPB: 0.44 (0.21), 0.56 (0.23), and 0.66 (0.29) μg mL<sup>−1</sup> vs. TPVB: 1.18 (0.39), 1.17 (0.30), and 1.13 (0.26) μg mL<sup>−1</sup> at 10, 30, and 60 min post-injection, respectively).</div></div><div><h3>Conclusion</h3><div>Compared with TPVB, SAPB provides non-inferior analgesia for children undergoing minimally invasive pectus excavatum repair surgery. Moreover, SAPB is associated with less intraoperative hemodynamic instability and lower plasma concentrations, suggesting it is a safe and valid alternative.</div></div><div><h3>Trial registration</h3><div>Chinese Clinical Trial Registry, identifier: ChiCTR 2,200,056,596.</div></div>","PeriodicalId":15506,"journal":{"name":"Journal of Clinical Anesthesia","volume":"107 ","pages":"Article 112003"},"PeriodicalIF":5.1000,"publicationDate":"2025-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Anesthesia","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0952818025002648","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ANESTHESIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Study objective
This study evaluated whether ultrasound-guided serratus anterior plane block (SAPB) provided non-inferior analgesic effects for minimally invasive pectus excavatum repair surgery compared with thoracic paravertebral block (TPVB).
Design
A noninferiority randomized trial.
Setting
West China Hospital of Sichuan University.
Patients
Seventy-four children aged 7–16 years who underwent minimally invasive pectus excavatum repair surgery were enrolled.
Intervention
Patients were randomly assigned to receive bilateral SAPB (n = 37) or TPVB (n = 37) after induction of anesthesia (0.5 mL kg−1 0.25 % of ropivacaine per side).
Measurements
Pain scores assessed via numerical rating scale (NRS) postoperatively; opioid consumption, block-related complications; and plasma ropivacaine concentrations were measured.
Main results
Median (IQR) pain scores for SAPB were 1 (1.0–2.0) and 1 (0.5–2.0) for those with TVPB 24 h postoperatively (effect size = 0.027; 95 % confidence interval, −0.42 to 0.47, P = 0.905), meeting the non-inferiority criterion with a pre-specified margin of 0.5. The TPVB group exhibited a greater incidence of hypotension (29.7 % vs. 8.1 %, p = 0.018). The ropivacaine concentrations were lower in the SAPB group at all measured time points (SAPB: 0.44 (0.21), 0.56 (0.23), and 0.66 (0.29) μg mL−1 vs. TPVB: 1.18 (0.39), 1.17 (0.30), and 1.13 (0.26) μg mL−1 at 10, 30, and 60 min post-injection, respectively).
Conclusion
Compared with TPVB, SAPB provides non-inferior analgesia for children undergoing minimally invasive pectus excavatum repair surgery. Moreover, SAPB is associated with less intraoperative hemodynamic instability and lower plasma concentrations, suggesting it is a safe and valid alternative.
Trial registration
Chinese Clinical Trial Registry, identifier: ChiCTR 2,200,056,596.
期刊介绍:
The Journal of Clinical Anesthesia (JCA) addresses all aspects of anesthesia practice, including anesthetic administration, pharmacokinetics, preoperative and postoperative considerations, coexisting disease and other complicating factors, cost issues, and similar concerns anesthesiologists contend with daily. Exceptionally high standards of presentation and accuracy are maintained.
The core of the journal is original contributions on subjects relevant to clinical practice, and rigorously peer-reviewed. Highly respected international experts have joined together to form the Editorial Board, sharing their years of experience and clinical expertise. Specialized section editors cover the various subspecialties within the field. To keep your practical clinical skills current, the journal bridges the gap between the laboratory and the clinical practice of anesthesiology and critical care to clarify how new insights can improve daily practice.